Literature DB >> 9165641

Coping with negative symptoms of schizophrenia: patient and family perspectives.

K T Mueser1, D P Valentiner, J Agresta.   

Abstract

An exploratory study was conducted of the strategies that schizophrenia patients and their relatives employ to cope with negative symptoms. Coping strategies and their perceived efficacy were elicited in semistructured interviews conducted separately with patients and relatives. Coping responses were coded according to the following dimensions: behavioral-cognitive, social-nonsocial, and problem focused-emotion focused. Overall, the number of coping strategies was related to perceived coping efficacy for both patients and relatives, regardless of the type of strategy. Perceived coping efficacy tended to be highest for apathy; intermediate for alogia, anhedonia, and inattention; and lowest for blunting. Relatives with more knowledge about schizophrenia used more coping strategies and reported higher levels of coping efficacy. Patient rejection by relatives and distress (either patient or relative) tended to not be related to coping strategies. The findings suggest that patients and relatives use a wide variety of strategies to cope with negative symptoms of schizophrenia. Future clinical work and research need to evaluate whether families may benefit from psychoeducational approaches to teaching them how to better manage negative symptoms.

Entities:  

Mesh:

Year:  1997        PMID: 9165641     DOI: 10.1093/schbul/23.2.329

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  13 in total

Review 1.  Illness management and recovery: a review of the literature.

Authors:  Alan B McGuire; Marina Kukla; Amethyst Green; Daniel Gilbride; Kim T Mueser; Michelle P Salyers
Journal:  Psychiatr Serv       Date:  2014-02-01       Impact factor: 3.084

2.  Fostering Recovery from Life-Transforming Mental Health Disorders: A Synthesis and Model.

Authors:  Carla A Green
Journal:  Soc Theory Health       Date:  2004-11-01

3.  Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.

Authors:  Stephanie G Park; Katiah Llerena; Julie M McCarthy; Shannon M Couture; Melanie E Bennett; Jack J Blanchard
Journal:  Schizophr Res       Date:  2012-01-21       Impact factor: 4.939

4.  The Illness Management and Recovery program: rationale, development, and preliminary findings.

Authors:  Kim T Mueser; Piper S Meyer; David L Penn; Richard Clancy; Donna M Clancy; Michelle P Salyers
Journal:  Schizophr Bull       Date:  2006-08-09       Impact factor: 9.306

5.  The cognitive, affective motivational and clinical longitudinal determinants of apathy in schizophrenia.

Authors:  Stéphane Raffard; Catherine Bortolon; Hanan Yazbek; Christophe Lançon; Michel Benoit; Joanna Norton; Delphine Capdevielle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-06-08       Impact factor: 5.270

6.  Quality of life and coping with schizophrenia symptoms.

Authors:  M Ritsner; I Ben-Avi; A Ponizovsky; I Timinsky; E Bistrov; I Modai
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

7.  Coping, productive time use, and negative mood among adults with severe mental illness: a daily diary study.

Authors:  Philip T Yanos; Michelle L West; Stephen M Smith
Journal:  Schizophr Res       Date:  2010-09-06       Impact factor: 4.939

Review 8.  Human facial expressions as adaptations: Evolutionary questions in facial expression research.

Authors:  K L Schmidt; J F Cohn
Journal:  Am J Phys Anthropol       Date:  2001       Impact factor: 2.868

9.  Coping with psychosis: an integrative developmental framework.

Authors:  David Roe; Philip T Yanos; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2006-12       Impact factor: 2.254

10.  Carers' hope, wellbeing and attitudes regarding recovery.

Authors:  Sarah Marshall; Frank Deane; Trevor Crowe; Angela White; David Kavanagh
Journal:  Community Ment Health J       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.